Articles on Immunology

THE INNATE IMMUNE SYSTEM

Host Innate Immune Responses to Microbial Pathogens

Journal: Current Vascular Pharmacology
Volume: 11,Issue: 2
Page: 123-132
Authors: Julie Delaloye and Thierry Calandra

Qualitative and Quantitative Variables that Affect the Potency of Fc- Mediated Effector Function In Vitro and In Vivo: Considerations for Passive Immunization Using Non-Neutralizing Antibodies

Journal: Current HIV Research
Volume: 11,Issue: 5
Page: 354-364
Authors: George K Lewis

The Brain-Immune-Gut Triangle: Innate Immunity in Psychiatric and Neurological Disorders

Journal: Current Immunology Reviews
Volume: 9,Issue: 4
Page: 241-248
Authors: Attila Szabo and Eva Rajnavolgyi

Role of Innate Immune System in Inflammation and Cardiac Remodeling After Myocardial Infarction

Journal: Current Vascular Pharmacology
Volume: 13,Issue: 1
Page: 20-25
Authors: Masafumi Takahashi

 

Contributor’s Comment

2-25-2015 10-54-32 AMhttp://bit.ly/1zyIjXJ

 

Recently Published Issue of the Journal Current Medicinal Chemistry

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Following are the articles from the journal Current Medicinal Chemistry, 22 Issue 11:


Article
: Imidazoles and Benzimidazoles as Tubulin-Modulators for Anti-Cancer Therapy

Author(s): Fernando C. Torres, M. Eugenia Garcia-Rubino, Cesar Lozano-Lopez, Daniel F. Kawano, Vera L. Eifler-Lima, Gilsane L. von Poser and Joaquin M. Campos

 

Article: A Simple and Reliable Approach for Assessing Anticancer Activity In Vitro

Author(s): Miguel Lopez-Lazaro

 

Article: Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance

Author(s): Yan Gao, Jacson K. Shen, Lara Milane, Francis J. Hornicek, Mansoor M. Amiji and Zhenfeng Duan

 

Article: Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments

Author(s): Ya-Ting Ji, Yan-Na Liu and Zhao-Peng Liu

 

Article: Inhibitors Targeting the Influenza Virus Hemagglutinin

Author(s): F. Li, C. Ma and J. Wang

 

Article: Investigation of Potential Inhibitors of Chorismate-Utilizing Enzymes

Author(s): Marketa Svarcova, Martin Kratky and Jarmila Vinsova

 

Article: Mexiletine Metabolites: A Review

Author(s): Alessia Catalano, Alessia Carocci and Maria Stefania Sinicropi

 

Article: Oleanolic Acid and Related Triterpenoids from Olives on Vascular Function: Molecular Mechanisms and Therapeutic Perspectives

Author(s): Rosalia Rodriguez-Rodriguez

 

For details, please visit: http://bit.ly/19Mo8jc

 

 

Contributor’s Comments

3-24-2015 4-25-06 PM

 

Bentham Open Access Article

images

THE ARTICLE ENTITLED ‘Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review‘ IN THE JOURNAL Current Alzheimer Research, 2015, 12, 116-146 IS NOW OPEN FOR ALL TO VIEW AND ACCESS.

_______________________________________________________________________

FOR ARTICLE INFORMATION, PLEASE VISIT:
http://www.eurekaselect.com/128201/article
FOR JOURNAL INFORMATION, PLEASE VISIT:
http://benthamscience.com/journal/abstracts.php?journalID=car&articleID=128201

SMI EVENT:::::Lyophilisation Europe – 29 – 30 June 2015 – London UK

2000X200DESCRIPTION: Spurred by the growth of the new drugs, the lyophilisation market is projected to reach $5,121.5 million by 2019. With the rising risk of contamination and the need for improved formulation methods of biological products, robust capabilities in lyophilisation and freeze drying methods have become critical for prolonging drug life span whilst maintaining its functionality and preventing it from damage.

Innovation and efficiency is requested at every level making SMi’s 3rd annual European conference on Lyophilisation, the perfect platform to strengthen knowledge in key principles such as PAT and QbD whilst keeping you at the forefront of technological breakthroughs to adapt to a competitive growing industry.

We have worked closely with a leading panel of experts such as Takeda, GSK, Boehringer-Ingelheim, Hovione, Novo Nordisk A/S, Baxter Bioscience and UCB BioPharma, to create an agenda that asks questions such as: What are the fundamentals of freeze drying and how can process development be optimised? How can risk-based approaches be integrated into QbD principles? How is spray drying a viable alternative to lyophilisation for achieving continuous production? How does PAT support scales up processes and to what degree has it been successful? What are the future prospects for continuous production processes? For further details and to register, visit http://www.smi-online.co.uk/goto/2015lyophilisation20.asp or contact the team on +44 (0)870 9090 711.

Lyophilisation Europe
29 – 30 June 2015
Holiday Inn Hotel Regents Park, London UK
URL: http://www.smi-online.co.uk/goto/2015lyophilisation20.asp

SMI EVENT:::::::Biobanking 22 – 23 JUNE 2015 – London UK

2OOX2OODESCRIPTION: With the global medical biobanking industry expected to reach $22.7 billion by 2018 and the increasing amount of sample and information sharing between biobanks and research facilities, SMi’s 5th annual BioBanking conference comes at the perfect time on 23rd & 24th June 2015, to discuss key topics surrounding best practice in specimen and repository preservation, future integrity of sample collections, confidentiality of research participants, plus much more!

We have worked closely with a leading panel of experts such as The UK Biobank, MHRA, Baby Biobank, Sanofi-Aventis, UK Stem Cell Bank, Brain Bank Consultants and Baby Biobank, to create an agenda that asks questions such as: How will regulatory changes in EU data protection impact current procedures? What should biobanks do after funding expires? What are the steps in building a successful biobanking network? When are incidental findings fed back to participants? What does the future hold for medical biobanks? PLUS MUCH MORE.  To register or for further information, visit http://www.smi-online.co.uk/goto/2015biobanking29.asp or contact the team on +44 (0)870 9090 711

Biobanking –
22 – 23 JUNE 2015
Holiday Inn, Regents Park Hotel, London UK
URL: http://www.smi-online.co.uk/goto/2015biobanking29.asp

 

Active 3 Months Free Trial

BENTHAM SCIENCE PUBLISHERS OFFERS FREE TRIAL FOR 3 MONTHS TO UNIVERSITIES, INSTITUTES AND LIBRARIES AROUND WITH WORLD.
FOLLOWING ARE THE UNIVERSITIES WHICH ARE AVAILING THIS OFFER TO ACCESS BENTHAM SCIENCE JOURnals:
King Fahad Medical City, Saudi Arabia
King Fahad Medical City is considered the largest and most advanced medical complex in the Middle East with a total capacity of 1095 beds. This colossal medical facility built at a cost of 2.3 billion Saudi Riyals comprises of four hospitals expected to treat annually more than 50,000 in-patients and over 600,000 out-patients.
The Main Hospital is a 459-bed hospital with specialty clinics for diagnosing and treating various diseases. Rehabilitation Hospital is a 159-bed hospital offering different levels of care, including inpatient, day rehabilitation, and outpatients’ services. A 246-bed Children’s Hospital and a 236-bed Maternity Hospital. In addition to the hospitals, King Fahad Medical City has 30 fully equipped operating rooms and contains the largest number of Intensive Care beds in the Region.
free trial2
Free Online Trial Request form: http://bit.ly/1BeXpmZ
Email for further assistance: marketing@benthamscience.org

Recently Published Issue of the Journal Current Molecular Medicine

Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Following are the articles from the journal Current Molecular Medicine, 15 Issue 2: 

Editorial: (Thematic Issue: Microphenotypes of Mental Disorders: A Systematic Approach to Study Disease Mechanisms)

Author(s): Akira Sawa, Satoshi Kida and Kazutaka Ikeda

 

Article: Microendophenotypes of Psychiatric Disorders: Phenotypes of Psychiatric Disorders at the Level of Molecular Dynamics, Synapses, Neurons, and Neural Circuits

Author(s): S. Kida and T. Kato

 

Article: Impaired DNA Damage Repair as a Common Feature of Neurodegenerative Diseases and Psychiatric Disorders

Author(s): H. Shiwaku and H. Okazawa

 

Article: Neurogenesis and Sensorimotor Gating: Bridging a Microphenotype and an Endophenotype

Author(s): N. Osumi, N. Guo, M. Matsumata and K. Yoshizaki

 

Article: Clinical Utility of Neuronal Cells Directly Converted from Fibroblasts of Patients for Neuropsychiatric Disorders: Studies of Lysosomal Storage Diseases and Channelopathy

Author(s): S. Kano, M. Yuan, R.A. Cardarelli, G. Maegawa, N. Higurashi, M. Gaval-Cruz, A.M. Wilson, C. Tristan, M.A. Kondo, Y. Chen, M. Koga, C. Obie, K. Ishizuka, S. Seshadri, R. Srivastava, T.A. Kato, Y. Horiuchi, T.W. Sedlak, Y. Lee, J.L. Rapoport, S. Hirose, H. Okano, D. Valle, P. O’Donnell, A. Sawa and M. Kai

Article: Common Mechanisms of Excitatory and Inhibitory Imbalance in Schizophrenia and Autism Spectrum Disorders

Author(s): R. Gao and P. Penzes

 

Article: Imaging Genetics and Psychiatric Disorders

Author(s): R. Hashimoto, K. Ohi, H. Yamamori, Y. Yasuda, M. Fujimoto, S. Umeda-Yano, Y. Watanabe, M. Fukunaga and M. Takeda

 

Article: Decoupling of N-Acetyl-Aspartate and Glutamate Within the Dorsolateral Prefrontal Cortex in Schizophrenia

Author(s): J.M. Coughlin, T. Tanaka, A. Marsman, H. Wang, S. Bonekamp, P.K. Kim, C. Higgs, M. Varvaris, R.A.E. Edden, M. Pomper, D. Schretlen, P.B. Barker and A. Sawa

 

Article: How Does Pain Induce Negative Emotion? Role of the Bed Nucleus of the Stria Terminalis in Pain-Induced Place Aversion

Author(s): M. Minami and S. Ide

For details, please visit: http://bit.ly/1N9IEXf

Highlighted Article of the Journal CNS & Neurological Disorders – Drug Targets

CNSNDDT-Articles_13-8For more information, click here: http://bit.ly/1BkYbhj